glp 1 triple agonist History of glucagon-like peptide-1 receptor agonists triple acting glp 1 🧬

I see many patients who say, Ill just wait for the new triple drug. As a doctor, I strongly advise against this strategy for three reasons: Obesity is a progressive disease

Exenatide improves endothelial function assessed by flow mediated dilation technique in subjects with type 2 diabetes: Results from an observational research

P., Bartchewsky, W

Stomach problems, sometimes severe, have been reported in people who use Wegovy

A 39-amino-acid peptide with a fatty diacid moiety attached for half-life extension is harder to synthesize correctly than shorter, simpler peptides

Focus on the influence of GLP-1-RA (e.g., Exenatide, Semaglutide, Liraglutide) on hMSC